Moreover, in vivo experiments, overexpressed GPR37 can promote tumorigenesis and growth of NSCLC in animals, whereas knocked down GPR37 can inhibit tumorigenesis and growth of NSCLC in animals. Here, GPR37 is linked to non-small cell lung carcinoma.